CME/CE: Updated Guidance on Managing C. difficile Infection
This course describes the newest recommendations on preferred and alternative treatments for...
Read MoreMar 9, 2022
This course describes the newest recommendations on preferred and alternative treatments for...
Read MoreMar 9, 2022
This course discusses the differences between guideline-based recommendations for common...
Read MoreMar 8, 2022
In patients with MS, dysfunctional visual search behavior may be one of the mechanisms that...
Read MoreMar 8, 2022
Radical nephrectomy and thrombectomy can effectively improve the prognosis of the 4% to 10% of...
Read MoreMar 7, 2022
Liver cancer is the third-highest cause of cancer-related deaths worldwide, and incidence of...
Read MoreMar 7, 2022
When compared with the general population, patients with cancer-associated thrombosis (CAT) have...
Read MoreMar 3, 2022
In patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors...
Read MoreMar 1, 2022
This course discusses a study that evaluated the relationship between extended hang times of...
Read MoreFeb 25, 2022
While thoracoscopic sub-lobar resection (SR) appears to result in similar oncologic outcomes...
Read MoreFeb 24, 2022
Among children diagnosed with MS, parental HRQOL mediates the relationship between that diagnosis...
Read MoreFeb 23, 2022
Updated data from the KEYNOTE-564 trial shows pembrolizumab disease-free survival persists long...
Read MoreFeb 23, 2022
Combination treatment with nivolumab plus axitinib has achieved a high response rate in...
Read MoreFeb 23, 2022
Biomarker analysis of the phase 2 TITAN-RCC trial identified specific immune cell-related...
Read MoreFeb 23, 2022
Results of the NeoAvAx trial indicate that the neoadjuvant combination of avelumab plus axitinib...
Read MoreFeb 23, 2022
In order to successfully navigate the ins and outs of necessities like insurance, technology...
Read MoreFeb 22, 2022
In early February, two senators introduced the Telehealth Extension and Evaluation Act to extend Medicare telehealth reimbursement waivers another 2 years following the end of the public health emergency declared due to the COVID pandemic.
Read MoreFeb 14, 2022
The purpose of the “Love Your Liver” (#LoveYourLiver) campaign is to educate the public and...
Read MoreFeb 14, 2022
Imagine for a moment the trauma a parent experiences when burying their child. This is an...
Read MoreFeb 14, 2022
Olfactory dysfunction (OD) can have important effects on QOL for patients and serves as a...
Read MoreFeb 11, 2022
Preoperative PET/CT provided information on standardized uptake value (SUV) and volumetric...
Read More